证券记录 · 已归档季度
OMCL
Omnicell, Inc. · Healthcare · Medical - Healthcare Information Services
13被追踪持有人
n/aΔ持有人
3.69M持有股份
$99.83M报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 51.82K | $1.76M | n/a | n/a |
| Q2 2026 | 98 | +2 | 36.92M | $1.52B | +8 | −7 |
| Q1 2026 | 100 | +1 | 36.98M | $1.23B | +6 | −5 |
| Q4 2025 | 99 | +2 | 40.13M | $1.82B | +2 | n/a |
| Q3 2025 | 18 | 0 | 22.98M | $699.67M | +1 | −1 |
| Q2 2025 | 15 | -1 | 21.34M | $627.32M | +1 | −2 |
| Q1 2025 | 13 | -1 | 6.74M | $235.79M | n/a | −1 |
| Q4 2024 | 14 | +1 | 6.20M | $275.97M | +1 | n/a |
| Q3 2024 | 12 | -1 | 3.89M | $169.70M | n/a | −1 |
| Q2 2024 | 13 | n/a | 3.69M | $99.83M | n/a | n/a |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (被动) | 1.10M | n/a | $29.83M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | D. E. Shaw & Co. ✦ | 1.09M | n/a | $29.45M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 3 | Wellington Management ✦ | 418.39K | n/a | $11.33M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 4 | Citadel Advisors ✦ | 389.64K | n/a | $10.55M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 131.30K | n/a | $3.55M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 123.89K | n/a | $3.35M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | PRIMECAP Management ✦ | 110.77K | n/a | $3.00M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Millennium Management ✦ | 97.00K | n/a | $2.63M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | Marshall Wace ✦ | 59.97K | n/a | $1.62M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | AQR Capital Management ✦ | 49.07K | n/a | $1.33M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | T. Rowe Price ✦ | 40.45K | n/a | $1.09M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Gotham Asset Management ✦ | 39.31K | n/a | $1.06M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Bridgewater Associates ✦ | 38.29K | n/a | $1.04M | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 2 持有人, 5.77M 股份, $5.60M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据